Global Pharma Saves 4 Months Recruitment Efforts With Digital Campaigning

A large global pharma initiated a phase III study testing the efficacy of combining two existing drugs in overactive bladder patients. The study planned to enroll 3,500 patients worldwide, 120 of which were to be recruited over a 10-month period across 15 sites in multiple countries in the Nordic region.

Trialbee was engaged from study start to ensure enrollment deadlines were met as planned. Trialbee provided the pharma a seamless patient recruitment experience powered by real‑time analytics. In this case study learn how clinical profile data, including epidemiology, target geography prevalence, comorbidities and other protocol‑specific criteria, in addition to patient-related data such as demographics, behavior, interests and needs were used to identify relevant patient populations.